UK approves Oxford-AstraZeneca COVID-19 vaccine

The UK has approved the Oxford-AstraZeneca COVID-19 vaccine.

The vaccine is the second to be approved by the UK.

It is said to be between 62 percent and 90 percent effective against the virus.

Its approval means that it is safe and effective for public use.

The vaccine was developed by scientists at Oxford University.

The UK is said to have ordered 100 million doses of the vaccine which will be administered on 50 million people — two doses each.

Earlier in December, the UK health regulator approved the use of Pfizer’s COVID-19 vaccine which is said to be 95 percent effective.

The UK began vaccination of the most vulnerable group in the country earlier in the month.

So far, the UK has recorded over two million cases of COVID-19 and over 71,000 fatalities.

A new strain of the infection which is said to be 70 times more contagious has been discovered in the country.